We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Theraly Fibrosis Inc. Licenses Scarab Genomics’ Bacterial Production Technologies for its Pharmaceutical Program

Product News   Feb 07, 2019

 
Theraly Fibrosis Inc. Licenses Scarab Genomics’ Bacterial Production Technologies for its Pharmaceutical Program

Credit: Scarab Genomics

FURTHER INFORMATION
 
 
 

Related Product News

Accelerating Development of Rapid Diagnostic Tests For Ebola

Product News

Mologic Ltd has announced that it has launched an accelerated program with the Institut Pasteur de Dakar, Senegal to develop a low-cost, high-performance rapid diagnostic test for Ebola.

READ MORE

Engineering Antibodies Against Animal Venom Toxins

Product News

Absolute Antibody Ltd. has announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms.

READ MORE

qPCR Master Mix for Reproducible Real-time PCR Experiments

Product News

Thermo Fisher Scientific has launched the Applied Biosystems™ PowerTrack™ SYBR™ Green PCR Master Mix.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE